{
    "2021-03-02": [
        [
            {
                "time": "",
                "original_text": "键凯科技—药物长效化的“送水人”",
                "features": {
                    "keywords": [
                        "键凯科技",
                        "药物长效化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "免疫 | 默沙东豪掷18.5亿美元囊获IL-2靶向疗法，恒瑞、信达和君实也有布局",
                "features": {
                    "keywords": [
                        "默沙东",
                        "IL-2靶向疗法",
                        "恒瑞",
                        "信达",
                        "君实"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "中航证券---医药生物行业周报：延续调整态势，关注结构性投资机会【行业研究】",
                "features": {
                    "keywords": [
                        "中航证券",
                        "医药生物",
                        "行业周报",
                        "调整态势",
                        "结构性投资机会"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-01",
                "original_text": "A股融资融券日报：两融余额增加77.25亿元（3月1日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}